Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pitukcheewanont Pisit Duke | Chief Medical Officer | 9 | $0 | $0 | 2024-12-12 |
| van Es-Johansson An | Director | 11 | $0 | $0 | 2024-12-12 |
| POWERS BRADLEY J | General Counsel | 27 | $0 | $0 | 2024-12-12 |
| Lawley Lori D | Principal Accounting Officer | 32 | $0 | $0 | 2024-12-12 |
| JOHNSON CHAD ALLEN | Director | 15 | $0 | $0 | 2024-12-12 |
| Schuchart Aaron | Chief Business Officer | 19 | $14.8K | $0 | 2024-12-12 |
| McKew John C. | Chief Scientific Officer | 40 | $0 | $106.0K | 2024-12-12 |
| McCracken Joseph S | Director | 16 | $103.8K | $0 | 2024-12-12 |
| LALANDE KEVIN M. | Director | 33 | $2.91M | $0 | 2024-12-12 |
| Raffin Thomas A. | Director | 16 | $9.7K | $0 | 2024-12-12 |
| Hawkins Richard J | Chief Executive Officer | 29 | $39.3K | $0 | 2024-12-12 |
| Zoth Lota S. | Director | 15 | $0 | $0 | 2024-12-12 |
| Karpf David B | Chief Medical Officer | 6 | $0 | $0 | 2023-02-01 |
| Langren Carl W. | Chief Financial Officer | 5 | $0 | $0 | 2021-04-01 |
| Kennedy Eugene P. | Chief Medical Officer | 4 | $0 | $0 | 2021-02-01 |
| Cunningham Emmett | Director | 2 | $0 | $0 | 2020-04-03 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| McCracken Joseph S | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| McCracken Joseph S | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| McCracken Joseph S | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| McCracken Joseph S | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,776 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 21,250 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 1,282 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 4,628 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 10,625 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 11,000 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 11,000 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 11,000 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 1,887 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 7,407 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 10,625 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,554 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 8,500 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 7,805 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 45,000 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 29,750 | — | $0 | 0 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 41,500 | — | $0 | 0 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 25,500 | — | $0 | 0 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,333 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,777 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 10,439 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,729 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 4,227 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,777 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 16,000 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 6,541 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 9,583 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 81,690 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 65,000 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 14,000 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 33,175 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 16,000 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,777 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,324 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 28,475 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 135,000 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer deriv | 2024-12-12 | 2024-12-13 | 19,624 | — | $0 | 0 | SEC↗ |
| McCracken Joseph S | Director | D To issuer | 2024-12-12 | 2024-12-13 | 15,721 | — | $0 | 0 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | D To issuer | 2024-12-12 | 2024-12-13 | 12,284 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer | 2024-12-12 | 2024-12-13 | 27 | — | $0 | 0 | SEC↗ |
| POWERS BRADLEY J | General Counsel | D To issuer | 2024-12-12 | 2024-12-13 | 6,307 | — | $0 | 0 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | D To issuer | 2024-12-12 | 2024-12-13 | 8,179 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer | 2024-12-12 | 2024-12-13 | 730,446 | — | $0 | 0 | SEC↗ |
| LALANDE KEVIN M. | Director | D To issuer | 2024-12-12 | 2024-12-13 | 1,076 | — | $0 | 0 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | D To issuer | 2024-12-12 | 2024-12-13 | 16,836 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | D To issuer | 2024-12-12 | 2024-12-13 | 9,406 | — | $0 | 0 | SEC↗ |
| van Es-Johansson An | Director | D To issuer | 2024-12-12 | 2024-12-13 | 1,100 | — | $0 | 0 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | D To issuer | 2024-12-12 | 2024-12-13 | 1,076 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | D To issuer | 2024-12-12 | 2024-12-13 | 13,153 | — | $0 | 0 | SEC↗ |
| Zoth Lota S. | Director | D To issuer | 2024-12-12 | 2024-12-13 | 2,187 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer | 2024-12-12 | 2024-12-13 | 4,469 | — | $0 | 0 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | D To issuer | 2024-12-12 | 2024-12-13 | 753,093 | — | $0 | 0 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2024-08-06 | 2024-08-06 | 3,407 | $1.89 | $6.4K | 12,653 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2024-08-01 | 2024-08-05 | 1,593 | $1.79 | $2.9K | 16,060 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2024-08-01 | 2024-08-05 | 229 | $1.79 | $410 | 12,284 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | F Tax w/h | 2024-07-01 | 2024-07-03 | 274 | $2.26 | $619 | 16,836 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| McCracken Joseph S | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| van Es-Johansson An | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | F Tax w/h | 2024-06-01 | 2024-06-04 | 320 | $2.25 | $720 | 16,610 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2024-04-03 | 2024-04-03 | 2,214 | $2.78 | $6.2K | 17,153 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 41,500 | — | $0 | 41,500 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award deriv | 2024-04-01 | 2024-04-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award deriv | 2024-04-01 | 2024-04-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award | 2024-04-01 | 2024-04-03 | 1,000 | $2.84 | $2.8K | 6,679 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award | 2024-04-01 | 2024-04-03 | 4,500 | $2.84 | $12.8K | 754,615 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,522 | $2.84 | $4.3K | 753,093 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2024-04-01 | 2024-04-03 | 2,000 | $2.84 | $5.7K | 20,403 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,036 | $2.84 | $2.9K | 19,367 | SEC↗ |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | A Award | 2024-04-01 | 2024-04-03 | 6,000 | $2.84 | $17.0K | 16,930 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award | 2024-04-01 | 2024-04-03 | 1,000 | $2.84 | $2.8K | 12,787 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2024-04-01 | 2024-04-03 | 274 | $2.84 | $778 | 12,513 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award | 2024-04-01 | 2024-04-03 | 900 | $2.84 | $2.6K | 6,649 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2024-04-01 | 2024-04-03 | 342 | $2.84 | $971 | 6,307 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2024-02-06 | 2024-02-07 | 438 | $3.03 | $1.3K | 18,403 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2024-02-01 | 2024-02-05 | 240 | $3.01 | $722 | 5,749 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 202 | $3.01 | $608 | 5,679 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 215 | $3.01 | $647 | 11,787 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 690 | $3.01 | $2.1K | 750,115 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 366 | $3.01 | $1.1K | 18,841 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2023-08-02 | 2023-08-03 | 3,407 | $3.21 | $10.9K | 18,707 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2023-08-01 | 2023-08-03 | 229 | $3.28 | $751 | 11,502 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2023-08-01 | 2023-08-03 | 1,593 | $3.28 | $5.2K | 22,114 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| McCracken Joseph S | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| van Es-Johansson An | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2023-04-04 | 2023-04-04 | 2,214 | $3.27 | $7.2K | 23,207 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2023-04-01 | 2023-04-04 | 1,522 | $3.31 | $5.0K | 750,805 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2023-04-01 | 2023-04-04 | 274 | $3.31 | $907 | 11,231 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2023-04-01 | 2023-04-04 | 1,036 | $3.31 | $3.4K | 25,421 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2023-04-01 | 2023-04-04 | 342 | $3.31 | $1.1K | 5,989 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2023-02-02 | 2023-02-03 | 439 | $3.53 | $1.5K | 26,457 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| Karpf David B | Chief Medical Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award deriv | 2023-02-01 | 2023-02-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award | 2023-02-01 | 2023-02-03 | 4,500 | $3.52 | $15.8K | 752,743 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 416 | $3.52 | $1.5K | 752,327 | SEC↗ |
| Karpf David B | Chief Medical Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 36 | $3.52 | $127 | 8,294 | SEC↗ |
| Karpf David B | Chief Medical Officer | A Award | 2023-02-01 | 2023-02-03 | 1,000 | $3.52 | $3.5K | 8,330 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 114 | $3.52 | $401 | 11,505 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award | 2023-02-01 | 2023-02-03 | 1,000 | $3.52 | $3.5K | 11,619 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2023-02-01 | 2023-02-03 | 2,000 | $3.52 | $7.0K | 27,102 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 206 | $3.52 | $725 | 26,896 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award | 2023-02-01 | 2023-02-03 | 900 | $3.52 | $3.2K | 6,462 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2023-02-01 | 2023-02-03 | 131 | $3.52 | $461 | 6,331 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award | 2023-02-01 | 2023-02-03 | 1,000 | $3.52 | $3.5K | 5,485 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | F Tax w/h | 2023-02-01 | 2023-02-03 | 104 | $3.52 | $366 | 5,381 | SEC↗ |
| McCracken Joseph S | Director | P Buy | 2022-11-16 | 2022-11-18 | 4,000 | $5.03 | $20.1K | 15,721 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | P Buy | 2022-09-23 | 2022-09-23 | 208 | $8.80 | $1.8K | 4,469 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | P Buy | 2022-09-21 | 2022-09-23 | 2,214 | $8.84 | $19.6K | 4,261 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | P Buy | 2022-09-20 | 2022-09-21 | 1,506 | $8.75 | $13.2K | 2,047 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | P Buy | 2022-09-19 | 2022-09-21 | 541 | $8.65 | $4.7K | 541 | SEC↗ |
| Karpf David B | Chief Medical Officer | F Tax w/h | 2022-09-01 | 2022-09-06 | 570 | $8.53 | $4.9K | 7,330 | SEC↗ |
| McCracken Joseph S | Director | P Buy | 2022-08-25 | 2022-08-26 | 3,170 | $8.60 | $27.3K | 11,721 | SEC↗ |
| Raffin Thomas A. | Director | P Buy | 2022-08-25 | 2022-08-26 | 1,150 | $8.46 | $9.7K | 9,406 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2022-08-02 | 2022-08-03 | 3,407 | $8.11 | $27.6K | 24,602 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2022-08-01 | 2022-08-03 | 229 | $8.17 | $1.9K | 10,119 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2022-08-01 | 2022-08-03 | 1,593 | $8.17 | $13.0K | 28,009 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2022-06-06 | 2022-06-07 | 169 | $7.62 | $1.3K | 29,102 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| McCracken Joseph S | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| van Es-Johansson An | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2022-04-05 | 2022-04-05 | 2,214 | $8.32 | $18.4K | 29,271 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2022-04-01 | 2022-04-05 | 1,466 | $9.23 | $13.5K | 748,243 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2022-04-01 | 2022-04-05 | 274 | $9.23 | $2.5K | 9,848 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2022-04-01 | 2022-04-05 | 1,036 | $9.23 | $9.6K | 31,485 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2022-04-01 | 2022-04-05 | 342 | $9.23 | $3.2K | 5,562 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| Karpf David B | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award deriv | 2022-02-01 | 2022-02-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2022-02-01 | 2022-02-03 | 173 | $10.02 | $1.7K | 749,709 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award | 2022-02-01 | 2022-02-03 | 4,500 | $10.02 | $45.1K | 749,882 | SEC↗ |
| Karpf David B | Chief Medical Officer | A Award | 2022-02-01 | 2022-02-03 | 400 | $10.02 | $4.0K | 7,900 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | F Tax w/h | 2022-02-01 | 2022-02-03 | 65 | $10.02 | $651 | 10,122 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award | 2022-02-01 | 2022-02-03 | 1,000 | $10.02 | $10.0K | 10,187 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2022-02-01 | 2022-02-03 | 1,500 | $10.02 | $15.0K | 32,621 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2022-02-01 | 2022-02-03 | 100 | $10.02 | $1.0K | 32,521 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award | 2022-02-01 | 2022-02-03 | 900 | $10.02 | $9.0K | 5,982 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2022-02-01 | 2022-02-03 | 78 | $10.02 | $782 | 5,904 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | F Tax w/h | 2022-02-01 | 2022-02-03 | 52 | $10.02 | $521 | 3,985 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award | 2022-02-01 | 2022-02-03 | 1,000 | $10.02 | $10.0K | 4,037 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-09-08 | 2021-09-10 | 10,000 | $11.21 | $112.1K | 730,446 | SEC↗ |
| McKew John C. | Chief Scientific Officer | S Sale | 2021-09-08 | 2021-09-10 | 2,214 | $11.30 | $25.0K | 31,012 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-09-07 | 2021-09-07 | 10,000 | $11.11 | $111.1K | 720,446 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-09-03 | 2021-09-07 | 8,100 | $11.35 | $91.9K | 710,446 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-09-02 | 2021-09-07 | 6,300 | $11.23 | $70.7K | 702,346 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-09-01 | 2021-09-01 | 4,589 | $10.87 | $49.9K | 696,046 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-31 | 2021-09-01 | 6,000 | $10.70 | $64.2K | 691,457 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-30 | 2021-09-01 | 8,625 | $10.52 | $90.7K | 685,457 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-27 | 2021-08-27 | 4,981 | $10.50 | $52.3K | 677,832 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-26 | 2021-08-27 | 6,200 | $10.07 | $62.4K | 672,851 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-25 | 2021-08-27 | 14,900 | $9.87 | $147.1K | 666,651 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-24 | 2021-08-24 | 10,775 | $9.45 | $101.8K | 651,751 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-23 | 2021-08-24 | 37,800 | $9.58 | $362.1K | 640,976 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-20 | 2021-08-24 | 35,679 | $8.73 | $311.5K | 603,176 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-19 | 2021-08-19 | 20,000 | $8.45 | $169.0K | 567,497 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-18 | 2021-08-19 | 28,870 | $8.73 | $252.0K | 547,497 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-17 | 2021-08-19 | 16,000 | $8.47 | $135.5K | 518,627 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-16 | 2021-08-16 | 31,000 | $7.96 | $246.8K | 502,627 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-13 | 2021-08-16 | 31,000 | $7.86 | $243.7K | 471,627 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | P Buy | 2021-08-12 | 2021-08-13 | 1,700 | $7.42 | $12.6K | 3,037 | SEC↗ |
| LALANDE KEVIN M. | Director | P Buy | 2021-08-12 | 2021-08-16 | 31,000 | $7.55 | $234.1K | 440,627 | SEC↗ |
| McCracken Joseph S | Director | P Buy | 2021-08-11 | 2021-08-13 | 7,475 | $7.55 | $56.4K | 8,551 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | P Buy | 2021-08-11 | 2021-08-13 | 300 | $7.35 | $2.2K | 1,337 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award deriv | 2021-08-01 | 2021-08-03 | 21,250 | — | $0 | 21,250 | SEC↗ |
| Lawley Lori D | Chief Financial Officer | A Award | 2021-08-01 | 2021-08-03 | 3,750 | — | $0 | 9,187 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2021-08-01 | 2021-08-03 | 20,000 | — | $0 | 33,226 | SEC↗ |
| Schuchart Aaron | Chief Business Officer | A Award deriv | 2021-06-01 | 2021-06-03 | 7,805 | — | $0 | 7,805 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| McCracken Joseph S | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| van Es-Johansson An | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 1,076 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 1,076 | SEC↗ |
| McCracken Joseph S | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 1,076 | SEC↗ |
| Raffin Thomas A. | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 8,256 | SEC↗ |
| van Es-Johansson An | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 1,100 | SEC↗ |
| Zoth Lota S. | Director | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 2,187 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | F Tax w/h | 2021-04-01 | 2021-04-05 | 1,522 | $12.25 | $18.6K | 745,382 | SEC↗ |
| Langren Carl W. | Chief Financial Officer | F Tax w/h | 2021-04-01 | 2021-04-05 | 683 | $12.25 | $8.4K | 11,494 | SEC↗ |
| Lawley Lori D | Principal Accounting Officer | F Tax w/h | 2021-04-01 | 2021-04-05 | 274 | $12.25 | $3.4K | 5,437 | SEC↗ |
| McKew John C. | Chief Scientific Officer | F Tax w/h | 2021-04-01 | 2021-04-05 | 1,036 | $12.25 | $12.7K | 13,226 | SEC↗ |
| POWERS BRADLEY J | General Counsel | F Tax w/h | 2021-04-01 | 2021-04-05 | 342 | $12.25 | $4.2K | 5,082 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 28,475 | — | $0 | 28,475 | SEC↗ |
| Kennedy Eugene P. | Chief Medical Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 31,475 | — | $0 | 31,475 | SEC↗ |
| Langren Carl W. | Chief Financial Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 11,475 | — | $0 | 11,475 | SEC↗ |
| Lawley Lori D | Principal Accounting Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 10,625 | — | $0 | 10,625 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award deriv | 2021-02-01 | 2021-02-03 | 33,175 | — | $0 | 33,175 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award deriv | 2021-02-01 | 2021-02-03 | 10,625 | — | $0 | 10,625 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award | 2021-02-01 | 2021-02-03 | 2,329 | — | $0 | 746,904 | SEC↗ |
| Kennedy Eugene P. | Chief Medical Officer | A Award | 2021-02-01 | 2021-02-03 | 939 | — | $0 | 11,423 | SEC↗ |
| Langren Carl W. | Chief Financial Officer | A Award | 2021-02-01 | 2021-02-03 | 939 | — | $0 | 12,177 | SEC↗ |
| Lawley Lori D | Principal Accounting Officer | A Award | 2021-02-01 | 2021-02-03 | 869 | — | $0 | 5,711 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2021-02-01 | 2021-02-03 | 1,078 | — | $0 | 14,262 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award | 2021-02-01 | 2021-02-03 | 869 | — | $0 | 5,424 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| Cunningham Emmett | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| McCracken Joseph S | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| Zoth Lota S. | Director | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| JOHNSON CHAD ALLEN | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 709 | SEC↗ |
| Cunningham Emmett | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 709 | SEC↗ |
| LALANDE KEVIN M. | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 709 | SEC↗ |
| McCracken Joseph S | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 709 | SEC↗ |
| Raffin Thomas A. | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 7,889 | SEC↗ |
| Zoth Lota S. | Director | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 1,820 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award deriv | 2020-04-01 | 2020-04-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Kennedy Eugene P. | Chief Medical Officer | A Award deriv | 2020-04-01 | 2020-04-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Langren Carl W. | Chief Financial Officer | A Award deriv | 2020-04-01 | 2020-04-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Lawley Lori D | Principal Accounting Officer | A Award deriv | 2020-04-01 | 2020-04-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award deriv | 2020-04-01 | 2020-04-03 | 65,000 | — | $0 | 65,000 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award deriv | 2020-04-01 | 2020-04-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hawkins Richard J | Chief Executive Officer | A Award | 2020-04-01 | 2020-04-03 | 25,000 | — | $0 | 744,575 | SEC↗ |
| Kennedy Eugene P. | Chief Medical Officer | A Award | 2020-04-01 | 2020-04-03 | 9,000 | — | $0 | 10,484 | SEC↗ |
| Langren Carl W. | Chief Financial Officer | A Award | 2020-04-01 | 2020-04-03 | 9,000 | — | $0 | 11,238 | SEC↗ |
| Lawley Lori D | Principal Accounting Officer | A Award | 2020-04-01 | 2020-04-03 | 4,500 | — | $0 | 4,842 | SEC↗ |
| McKew John C. | Chief Scientific Officer | A Award | 2020-04-01 | 2020-04-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| POWERS BRADLEY J | General Counsel | A Award | 2020-04-01 | 2020-04-03 | 4,500 | — | $0 | 4,555 | SEC↗ |